Foghorn Therapeutics (FHTX) Other Gross PP&E Adjustments: 2020-2025
Historic Other Gross PP&E Adjustments for Foghorn Therapeutics (FHTX) over the last 5 years, with Sep 2025 value amounting to $16.1 million.
- Foghorn Therapeutics' Other Gross PP&E Adjustments rose 1997.91% to $16.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.0 million, marking a year-over-year increase of 351.41%. This contributed to the annual value of -$1.5 million for FY2024, which is 85.50% up from last year.
- Per Foghorn Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at $16.1 million for Q3 2025, which was up 4.53% from $15.4 million recorded in Q2 2025.
- In the past 5 years, Foghorn Therapeutics' Other Gross PP&E Adjustments ranged from a high of $22.0 million in Q1 2021 and a low of -$18.0 million during Q2 2021.
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was -$1.5 million (2024), whereas its average is -$15,182.
- In the last 5 years, Foghorn Therapeutics' Other Gross PP&E Adjustments plummeted by 165.18% in 2022 and then surged by 1,997.91% in 2025.
- Foghorn Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at -$17.0 million in 2021, then increased by 22.15% to -$13.3 million in 2022, then grew by 24.35% to -$10.0 million in 2023, then surged by 85.50% to -$1.5 million in 2024, then soared by 1,997.91% to $16.1 million in 2025.
- Its last three reported values are $16.1 million in Q3 2025, $15.4 million for Q2 2025, and $5.0 million during Q1 2025.